Xiaolu Duan

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Venues

Molecular carcinogenesis

PeerJ

Oxidative medicine and cellular longevity

Cancer science

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaofeng Zhou, Sicheng Dong, Yuhao Zhou, Zhiqing He, Zhixiong Zhang, Liqiong Liao, Bangyu Zou, Xiaopeng Zheng, Kaoqing Peng, Xiaolu Duan
EMX2 inhibits clear cell renal cell carcinoma progress via modulating Akt/FOXO3a pathway. Molecular carcinogenesis 63 (5) (2024)
Xiaofeng Zhou, Sicheng Dong, Yuhao Zhou, Zhiqing He, Zhixiong Zhang, Liqiong Liao, Bangyu Zou, Xiaopeng Zheng, Kaoqing Peng, Xiaolu Duan
EMX2 inhibits clear cell renal cell carcinoma progress via modulating Akt/FOXO3a pathway. Molecular carcinogenesis 63 (5) (2024)
Xiaofeng Zhou, Sicheng Dong, Yuhao Zhou, Zhiqing He, Zhixiong Zhang, Liqiong Liao, Bangyu Zou, Xiaopeng Zheng, Kaoqing Peng, Xiaolu Duan
EMX2 inhibits clear cell renal cell carcinoma progress via modulating Akt/FOXO3a pathway. Molecular carcinogenesis (2024)
Xiaofeng Zhou, Sicheng Dong, Yuhao Zhou, Zhiqing He, Zhixiong Zhang, Liqiong Liao, Bangyu Zou, Xiaopeng Zheng, Kaoqing Peng, Xiaolu Duan
EMX2 inhibits clear cell renal cell carcinoma progress via modulating Akt/FOXO3a pathway. Molecular carcinogenesis 63 (5) (2024)
Lingyue An, Weizhou Wu, Shujue Li, Yongchang Lai, Dong Chen, Zhican He, Zhenglin Chang, Peng Xu, Yapeng Huang, Min Lei, Zheng Jiang, Tao Zeng, Xinyuan Sun, Xuan Sun, Xiaolu Duan, Wen-Qi Wu
Escherichia coli Aggravates Calcium Oxalate Stone Formation via PPK1/Flagellin-Mediated Renal Oxidative Injury and Inflammation. Oxidative medicine and cellular longevity 2021 (2021)
Tuo Deng, Xueming Lin, Xiaolu Duan, Zihao He, Zhijian Zhao, Guohua Zeng
Prostate cancer patients can benefit from 5-alpha-reductase inhibitor treatment: a meta-analysis. PeerJ 8 (2020)
Zihao He, Xiaolu Duan, Guohua Zeng
Identification of potential biomarkers and pivotal biological pathways for prostate cancer using bioinformatics analysis methods. PeerJ 7 (2019)
Zhenzhen Kong, Tuo Deng, Mengping Zhang, Zhijian Zhao, Yang Liu, Lianmin Luo, Chao Cai, Wenqi Wu, Xiaolu Duan
β-arrestin1-medieated inhibition of FOXO3a contributes to prostate cancer cell growth in vitro and in vivo. Cancer science 109 (6) (2018)

Xiaolu Duan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xiaolu Duan